Please Wait...

Books and Book Sections

Books and Book Sections

2014

Miller CG, Krasnow J, Schwartz LH. Medical Imaging in Clinical Trials. Published by Springer-Verlag London Ltd. 2014.

Hide All Authored Chapters

  • Medical Imaging Modalities
    • H Ahmad, HJ Yu, CG Miller
  • The Metrics and New Imaging Marker Qualification in Medical Imaging Modalities
    • CG Miller
  • Radiation Risks and Dosimetry Assessment
    • D Pearson
  • Imaging Review Charters and Operational Considerations
    • AM Perrone, JA Villetard
  • Defining the Radiological Blinded Read and Adjudication
    • CG Miller
  • Medical Imaging in Drug Development
    • J Krasnow
  • Evaluating and Working with an Imaging Core Laboratory
    • ES Forsthoffer, J Krasnow
  • Monitoring Responses to Therapy in Oncology
    • B Zhao, LH Schwartz
  • Cardiac Imaging in Clinical Trials
    • GP Heyrich, J Krasnow
  • Neuroimaging in Clinical Trials
    • SN Niogi, AJ Tsiouris
  • Imaging in Musculoskeletal, Metabolic, Endocrinological, and Pediatric Clinical Trials
    • CG Miller, HJ Yu, Cv Kuijk
  • Body Composition
    • JA Shepherd
  • Optical Coherence Tomography as a Biomarker in Clinical Trials for Ophthalmology and Neurology
    • RC Sergott
  • Nuclear Medicine: An Overview of Imaging Techniques, Clinical Applications and Trials
    • A Mehndiratta, P Anandaraj
  • Contrast Agents in Radiology
    • Hv Tengg-Kobligk, A Mehndiratta
  • Pharmaceutical Industry Perspective Regarding Imaging Techniques
    • J Krasnow

2008

Reid D, Miller CG. Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Published by Springer-Verlag London Ltd. 2008.

Hide All Authored Chapters

  • Introduction
    • DM Reid
  • Historical and Current Perspectives on Management of Osteoarthritis and Rheumatoid Arthritis
    • S Dubey, AO Adebajo
  • Development of Biological Therapies for Inflammatory Arthritis
    • N Basu
  • Study Design and End Points for Rheumatoid Arthritis Trials
    • P Geusens, CG Miller
  • Study Design and End Points in Ankylosing Spondylitis Clinical Trials
    • Dvd Heijde
  • Trial Design and Outcomes in Osteoarthritis
    • N Arden
  • Ethical Considerations
    • D Pearson
  • Organization of the Clinical Trial by the Sponsor
    • CG Miller
  • Organization of the Trial attheInvestigator Site
    • J Shotton, DM Reid
  • Role of the Imaging Core Laboratory in Rheumatoid Arthritis and Osteoarthritis Clinical Trials
    • MD Endres, AM Baratelle
  • Biochemical Markers of Rheumatoid Arthritis and Osteoarthritis: Clinical Utility and Practical Considerations
    • MR Ehlers, ET Leary
  • Data Analysis and Presentation: Writing a Paper for Publication
    • D Pearson
  • Radiographic Imaging End Points in Rheumatoid Arthritis Trials
    • AM Baratelle, Dvd Heijde
  • Radiography in Clinical Trials Investigating Osteoarthritis
    • Cv Kuijk
  • Use of Quantitative Magnetic Resonance Imaging in the Cross-Sectional and Longitudinal Evaluation of Structural Changes in Knee Osteoarthritis Patients
    • JP Raynauld
  • Biochemical Markers as Surrogate End Points of Joint Disease
    • LS Lohmander, DR Eyre
  • Role of Genetics and Genomics in Clinical Trials in Osteoarthritis and Rheumatoid Arthritis
    • SH Ralston
  • Cost-Effectiveness of New Biologics for Rheumatoid Arthritis and Osteoarthritis
    • YB Vergel, D Torgerson

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

A great resource for Alzheimers's research teams. https://t.co/qhVP6ImwoO
bioclinica (20 hours ago)
RT @bioclinica: #Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most pressin…
bioclinica (21 hours ago)
RT @Xtalks: Trends in #Pharmacovigilance – Market Research and Future Impact This webinar will discuss an overview of key findings within r…
bioclinica (21 hours ago)
RT @IntClinTrials: Patient loss and can reduced by introducing new methods during the follow-up period. Martin Collyer at @bioclinica tells…
bioclinica (21 hours ago)
@bioclinica experts talk candidly about #Alzheimer's research & where improvements can be made. Joyce Suhy, Marieke… https://t.co/u1Wmu41jRr
bioclinica (21 hours ago)
RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen